Brown Advisory’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-277,471
Closed -$4.05M 1078
2021
Q1
$4.05M Buy
277,471
+257,099
+1,262% +$3.76M 0.01% 499
2020
Q4
$354K Sell
20,372
-835,296
-98% -$14.5M ﹤0.01% 847
2020
Q3
$15.7M Buy
855,668
+49,554
+6% +$909K 0.03% 259
2020
Q2
$14.4M Buy
806,114
+44,962
+6% +$803K 0.03% 262
2020
Q1
$12.3M Buy
761,152
+7,816
+1% +$127K 0.04% 251
2019
Q4
$13.6M Buy
753,336
+23,538
+3% +$424K 0.03% 288
2019
Q3
$14.8M Buy
729,798
+73,343
+11% +$1.49M 0.04% 269
2019
Q2
$14.5M Buy
656,455
+3,061
+0.5% +$67.7K 0.04% 282
2019
Q1
$8.91M Sell
653,394
-17,709
-3% -$242K 0.03% 362
2018
Q4
$6.07M Buy
671,103
+11,837
+2% +$107K 0.02% 390
2018
Q3
$10.9M Buy
659,266
+25,222
+4% +$416K 0.03% 321
2018
Q2
$8.88M Sell
634,044
-3,933
-0.6% -$55.1K 0.03% 353
2018
Q1
$7.05M Buy
637,977
+4,942
+0.8% +$54.6K 0.02% 350
2017
Q4
$5.57M Buy
633,035
+39,014
+7% +$343K 0.02% 390
2017
Q3
$7.93M Buy
594,021
+31,211
+6% +$417K 0.03% 332
2017
Q2
$8.08M Buy
562,810
+111,274
+25% +$1.6M 0.02% 341
2017
Q1
$9.55M Buy
451,536
+115,536
+34% +$2.44M 0.03% 301
2016
Q4
$9.46M Buy
336,000
+13,098
+4% +$369K 0.03% 295
2016
Q3
$8.65M Buy
322,902
+25,152
+8% +$674K 0.03% 295
2016
Q2
$5.03M Buy
297,750
+55,728
+23% +$941K 0.02% 358
2016
Q1
$5.14M Buy
242,022
+41,104
+20% +$873K 0.02% 356
2015
Q4
$4.61M Buy
200,918
+5,937
+3% +$136K 0.02% 376
2015
Q3
$3.91M Buy
194,981
+15,099
+8% +$303K 0.01% 393
2015
Q2
$5.2M Sell
179,882
-41,631
-19% -$1.2M 0.02% 341
2015
Q1
$6.77M Sell
221,513
-2,387
-1% -$73K 0.02% 320
2014
Q4
$3.65M Buy
+223,900
New +$3.65M 0.01% 390